Navigation Links
FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
Date:2/28/2011

nd included syncope, mixed disturbance of emotions (similar to behaviors prior to study start), poison ivy, and a nonintentional overdose in a sibling of a study participant. All SAEs were considered by the investigator to be unrelated to INTUNIV.(2)

"This approval marks a significant development in our ADHD portfolio -- one that may help to address symptoms that many children with ADHD may experience while on stimulant treatment," said Michael Yasick, Senior Vice President of Shire's ADHD Business Unit. "We understand that every child is unique, and it is our goal to offer treatment options for ADHD in a variety of situations, whether a child could benefit from treatment with a stimulant, nonstimulant, or both."

About INTUNIV

INTUNIV is available in four doses -- 1 mg, 2 mg, 3 mg, and 4 mg.(1)  INTUNIV should be taken once a day.(1)  The active ingredient in INTUNIV is guanfacine. INTUNIV is not a central nervous system (CNS) stimulant or a controlled substance.(1)  It is not likely to cause dependence or be abused.(1)

IMPORTANT SAFETY INFORMATION

INTUNIV should not be used in patients with a history of hypersensitivity to guanfacine or any of its inactive ingredients or by patients taking other products containing guanfacine (eg, TENEX®).

Hypotension, bradycardia, and syncope were observed in clinical trials. Use INTUNIV with caution in treating patients who have experienced hypotension, heart block, bradycardia, or syncope, or who may have a condition that predisposes them to syncope; are treated concomitantly with antihypertensives or other drugs that can reduce blood pressure or heart rate or increase the risk of syncope. Heart rate and blood pressure should be measured prior to initiation of therapy, followin
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves Edarbi to Treat High Blood Pressure
2. FDA Approves EDARBI (azilsartan medoxomil) for the Treatment of Hypertension
3. FDA Approves Product to Prevent Bleeding in People With Rare Genetic Defect
4. FDA Approves First 3-D Mammography Imaging System
5. FDA Approves 1st Pacemaker Designed to Work Safely During Some MRI Exams
6. FDA Approves Hologics Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical
7. FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women
8. FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
9. FDA Approves Viibryd to Treat Major Depressive Disorder
10. FDA Approves Head Lice Treatment for Children and Adults
11. FDA Approves Opioid Analgesic to Help Cancer Patients Manage Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical ... therapeutics for the treatment of cancer and diseases of ... data from three of its most advanced oncology programs ... 106 th Annual Meeting being held from April ... USA. The presentation on the BNC105 ...
(Date:4/16/2015)... April 16, 2015 Vanda Pharmaceuticals Inc. (Vanda) ... the development and commercialization of products for the treatment ... release results for the first quarter of 2015 on ... The Company will host a conference call ... during which Vanda management will discuss the first quarter ...
(Date:4/16/2015)... 16, 2015 A drug commonly taken to prevent ... with multiple sclerosis (MS), according to a study released today ... 67th Annual Meeting in Washington, DC , ... of people with MS experience at some point in their ... nerve carrying vision from the eye to the brain gets ...
Breaking Medicine Technology:Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Epilepsy Drug May Preserve Eyesight for People with MS 2
... Calif., Nov. 5 Bionovo, Inc. (Nasdaq: BNVI ... the unmet needs in women,s health and oncology, today ... three months ended September 30, 2009. , Subsequent to ... successfully completed a public offering and issued approximately 31 ...
... , SAN DIEGO, Nov. 5, 2009 Amylin Pharmaceuticals, Inc. ... Annual Credit Suisse Healthcare Conference in Phoenix, Arizona on Wednesday, ... ET. Mark Foletta, senior vice president of finance and ... corporate overview. , The audio portion of the presentation will ...
Cached Medicine Technology:Bionovo Announces Third Quarter 2009 Highlights and Financial Results 2Bionovo Announces Third Quarter 2009 Highlights and Financial Results 3Bionovo Announces Third Quarter 2009 Highlights and Financial Results 4Bionovo Announces Third Quarter 2009 Highlights and Financial Results 5Bionovo Announces Third Quarter 2009 Highlights and Financial Results 6Bionovo Announces Third Quarter 2009 Highlights and Financial Results 7Bionovo Announces Third Quarter 2009 Highlights and Financial Results 8Bionovo Announces Third Quarter 2009 Highlights and Financial Results 9
(Date:4/18/2015)... 18, 2015 Carinsurancequotesinfo.com has released a ... cover physical injuries caused by a car accident. ... coverage for a vehicle. A policy can pay for ... accident. Drivers should always carry appropriate coverage when they ... can be bought with several important riders that offer ...
(Date:4/18/2015)... "I wanted to live a ... healthful juice that contained essential vitamins, minerals and ... increases my energy, improves skin elasticity and gives ... Tapp's Juice to contain fruits, vegetables and other ... and mental fatigue. It features a great taste. ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Lower-auto-insurance.com has ... accurate auto insurance quotes . , ... policies by comparing quotes. A professional insurance brokerage website ... insurance quotes, in a simple, convenient way. The whole ... to anyone. , Comparing online car insurance quotes ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 More than ... sale now at TheCelebrityDresses.com, the #1 online store carrying ... ongoing many girls have got their perfect dresses for ... the celebrity fashion prom dresses at TheCelebrityDresses.com would be ... designed more than 2000 prom dresses inspired by the ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 PHOENIX, ARIZONA ... County, along with 11 other secure destruction professionals across ... Destruction Specialists (CSDS). He will now display “CSDS” as ... were offered before the National Association of Information Destruction ... and another Grapevine, Texas. Of the 20 people who ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2
... Calif., May 7 The CPF today announced that the ... would authorize $16 million in new federal funding for pulmonary ... 27 Members of the U.S. House of Representatives. The ... and awareness of pulmonary fibrosis, a terminal lung disease with ...
... HMSY ) today announced that it will present ... Conference, which will be held Tuesday, May 12 ... City. The Company will present on Tuesday, May 12th at ... be accessed through our website at http://www.hms.com/investor_relations/investors_presentations.asp ...
... Conseco, Inc. (NYSE: CNO ) today responded ... subscribers who hold Conseco, Inc. stock vote for eight ... dissident nominee for the ninth director up for election."RMG ... to elect a dissident at Conseco,s upcoming annual meeting ...
... Facial Surgery in a Live Case Study for TWTRCON ... TWTRCON SF 09, the first conference focused on ... Operation Smile would be launching a groundbreaking new fundraising ... creating a live case study in which TWTRCON attendees ...
... May 7 /PRNewswire/ - Axela Inc., is pleased to ... dotLab(R) System that provides technical controls to support compliance ... will be of particular interest to those working in ... secure database, audit trails, electronic signature controls and user ...
... the U.S. once again a resounding successNEW YORK, May ... friends and supporters, joined the more than 10,000 people ... April 25th to celebrate the 15th Parkinson,s Unity Walk ... Parkinson,s disease research.This year marked an incredible year for ...
Cached Medicine News:Health News:Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act 2009 Increases to 27 Members 2Health News:Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act 2009 Increases to 27 Members 3Health News:Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act 2009 Increases to 27 Members 4Health News:Operation Smile To Launch Groundbreaking 140 Smiles Fundraising Campaign at TWTRCON SF 09 2Health News:Operation Smile To Launch Groundbreaking 140 Smiles Fundraising Campaign at TWTRCON SF 09 3Health News:Axela introduces software to support 21 CFR Part 11 Compliance for Regulated Environments 2Health News:15th Parkinson's Unity Walk A Step in the Right Direction for Parkinson's Community 2Health News:15th Parkinson's Unity Walk A Step in the Right Direction for Parkinson's Community 3
P-Series Cystourethroscope Short Bridge, examining...
Short single-horn bridge for insertion of instruments...
Albarran double-horn bridge for use with sheaths from 20-25 Fr and designed for accurate articulation of flexible devices....
Designed for accurate articulation of flexible devices....
Medicine Products: